You act as a paraphrase tool. Your role involves understanding the provided text…
- User
System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite. Output your response with the following format : Positive : Negative :
User: We rely on third parties for various components and processes for our product candidates. We may not be able to achieve multiple sourcing because there may be no acceptable second source, other companies may choose not to work with us, or the component or process sought may be so new that a second source does not exist or does not exist on acceptable terms. There may be a disruption or delay in the performance of our third-party contractors, suppliers or collaborators which is beyond our control. If such third parties are unable to satisfy their commitments to us, the development of our products would be adversely affected. Therefore, it is possible that our development plans will have to be slowed down or stopped completely at times due to our inability to obtain required raw materials, components, and outsourced processes at an acceptable cost, if at all, or to get a timely response from vendors. We have limited manufacturing capability and must rely on third-party manufacturers to manufacture our clinical supplies and commercial products, if and when approved, and if they fail to meet their obligations, the development and commercialization of our products could be adversely affected. We have limited manufacturing capabilities and experience. Our drug candidates are composed of multiple components and require specialized formulations for which scale-up and manufacturing could be difficult. We have limited experience in such scale-up Assistant:
- Assistant
Positive: We depend on external parties to supply various components and undertake processes for our product candidates. Achieving multiple sources might not be feasible, as an acceptable alternative might be unavailable, other companies might decline collaboration, or the required component or process might be too novel to have a second source or not have one on acceptable conditions. Our third-party contractors, suppliers, or collaborators may experience interruptions or delays that are beyond our control. If these third parties cannot fulfill their responsibilities to us, the development of our products might be negatively impacted. Therefore, there could be instances where our development plans need to be slowed down or halted entirely due to difficulties in acquiring the necessary raw materials, components, and outsourced processes within acceptable costs or receiving timely responses from vendors. We possess limited manufacturing capabilities and must rely on third-party manufacturers for the production of our clinical supplies and commercial products, if and when approved. Should they fail in meeting their obligations, the development and commercialization of our products might be at risk. Our drug candidates consist of numerous components and need specialized formulations, making scale-up and manufacturing challenging, compounded by our limited experience in such scale-up processes.
Negative: We do not rely on third parties for the components and processes related to our product candidates. We can easily achieve multiple sourcing as acceptable second sources are available, companies readily choose to work with us, and the components or processes are widely established. There are no disruptions or delays in performances by our third-party contractors, suppliers, or collaborators, and their performance is completely within our control. If such third parties fail to meet their commitments, it will have no adverse effect on the development of our products. Consequently, our development plans can proceed smoothly without any slowdown or complete halt due to challenges in acquiring necessary raw materials or components or receiving a prompt response from vendors. We have extensive manufacturing capability and do not need to rely on third-party manufacturers for our clinical supplies and commercial products. Even if challenges arise, it will not adversely affect the development and commercialization of our products. Our drug candidates are simple, and manufacturing and scale-up processes pose no difficulty, backed by our vast experience in such tasks.